The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
A decade of fragment-based drug design: strategic advances and lessons learned
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Self-citationDiscovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Self-citationLigand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
Virtual screening of chemical libraries
Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
NMR Spectroscopy Techniques for Screening and Identifying Ligand Binding to Protein Receptors
Meyer, B., & Peters, T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390233 · Cited by 1,039
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
The role of Bcl-2 family members in tumorigenesis
Kirkin, V., Joos, S., & Zörnig, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.009 · Cited by 548
Functionality maps of binding sites: A multiple copy simultaneous search method
Miranker, A., & Karplus, M. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110104 · Cited by 544
Ligand efficiency indices as guideposts for drug discovery
Abad-Zapatero, C., & Metz, J. T. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03386-6 · Cited by 527
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data
Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 522
Self-citationDynamic Combinatorial Chemistry
Lehn, J.-M., & Eliseev, A. V. (2001) · Science · doi:10.1126/science.1060066 · Cited by 403
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Tethering: Fragment-Based Drug Discovery
Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385
Liu, G., Huth, J. R., Olejniczak, E. T., Mendoza, R. R., DeVries, P. J., Leitza, S. T., Reilly, E. B., Okasinski, G. F., Fesik, S. W., & von Geldern, T. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000503f · Cited by 359
Virtual Exploration of the Small‐Molecule Chemical Universe below 160 Daltons
Fink, T., Bruggesser, H., & Reymond, J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462457 · Cited by 353
Fragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Discovering novel ligands for macromolecules using X-ray crystallographic screening
Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322
Self-citationTheory and Applications of NMR-Based Screening in Pharmaceutical Research
Lepre, C. A., Moore, J. M., & Peng, J. W. (2004) · Chemical Reviews · doi:10.1021/cr030409h · Cited by 322
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Self-citationDiscovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0507532 · Cited by 292
Self-citationRecent advances in matrix metalloproteinase inhibitor research
Beckett, R. P., Davidson, A. H., Drummond, A. H., Huxley, P., & Whittaker, M. (1996) · Drug Discovery Today · doi:10.1016/1359-6446(96)89115-x · Cited by 281
Can cell systems biology rescue drug discovery?
Butcher, E. C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1754 · Cited by 276
The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 271
Fragment-Based Drug Design: How Big Is Too Big?
Hajduk, P. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060511h · Cited by 265
Self-citationDiscovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly
Braisted, A. C., Oslob, J. D., Delano, W. L., Hyde, J., McDowell, R. S., Waal, N., Yu, C., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256
Integrating virtual screening in lead discovery
Oprea, T. I., & Matter, H. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.06.008 · Cited by 250
Critical review of the role of HTS in drug discovery
Macarron, R. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.02.001 · Cited by 241
Szczepankiewicz, B. G., Liu, G., Hajduk, P. J., Abad-Zapatero, C., Pei, Z., Xin, Z., Lubben, T. H., Trevillyan, J. M., Stashko, M. A., Ballaron, S. J., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0296733 · Cited by 231
Self-citationNMR-based screening in drug discovery
Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1999) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003528 · Cited by 229
Self-citationHuth, J. R., Mendoza, R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 228
Self-citationRescuing drug discovery: in vivo systems pathology and systems pharmacology
van der Greef, J., & McBurney, R. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1904 · Cited by 209
Card, G. L., Blasdel, L., England, B. P., Zhang, C., Suzuki, Y., Gillette, S., Fong, D., Ibrahim, P. N., Artis, D. R., Bollag, G., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1059 · Cited by 208
Library Design for Fragment Based Screening
Schuffenhauer, A., Ruedisser, S., Marzinzik, A., Jahnke, W., Selzer, P., & Jacoby, E. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054637700 · Cited by 203
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Gill, A. L., Frederickson, M., Cleasby, A., Woodhead, S. J., Carr, M. G., Woodhead, A. J., Walker, M. T., Congreve, M. S., Devine, L. A., Tisi, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049575n · Cited by 186
Fragment‐based Approaches in Drug Discovery
(2006) · Methods and Principles in Medicinal Chemistry · doi:10.1002/3527608761 · Cited by 181
Rediscovering the sweet spot in drug discovery
Brown, D., & Superti-Furga, G. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02902-7 · Cited by 176
Improving the hit-to-lead process: data-driven assessment of drug-like and lead-like screening hits
Wunberg, T., Hendrix, M., Hillisch, A., Lobell, M., Meier, H., Schmeck, C., Wild, H., & Hinzen, B. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03700-1 · Cited by 152
New assay technologies for high-throughput screening
Silverman, L., Campbell, R., & Broach, J. R. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80015-x · Cited by 151 · cited 1×
“To improve the chances of finding agents that are active against these targets, technologies such as combinatorial chemistry and ultra-high-throughput screening (HTS) approaches have considerably expanded the numbers of compounds that can be evaluated for their biological activit”
BackgroundEfficient synthetic inhibitors of anthrax lethal factor
Forino, M., Johnson, S. L., Wong, T. Y., Rozanov, D. V., Savinov, A. Y., Li, W., Fattorusso, R., Becattini, B., Orry, A. J. W., Jung, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502733102 · Cited by 128
Diffusion-Edited NMR−Affinity NMR for Direct Observation of Molecular Interactions
Lin, M., Shapiro, M. J., & Wareing, J. R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963654+ · Cited by 124
A General NMR Method for Rapid, Efficient, and Reliable Biochemical Screening
Dalvit, C., Ardini, E., Flocco, M. M., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja038128e · Cited by 122
Components of Successful Lead Generation
Davis, A., Keeling, D., Steele, J., Tomkinson, N. P., & Tinker, A. C. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828411 · Cited by 110
Characterization of protein-ligand interaction sites using experimental and computational methods.
Vajda, S., & Guarnieri, F. (2006) · PubMed · Cited by 109
Wada, C. K., Holms, J. H., Curtin, M. L., Dai, Y., Florjancic, A. S., Garland, R. B., Guo, Y. P., Heyman, H. R., Stacey, J. R., Steinman, D. H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103920 · Cited by 106
Choong, I., Lew, W., Lee, D. M., Pham, P., Burdett, M. T., Lam, J. W., Wiesmann, C., Luong, T. N., Fahr, B. J., DeLano, W. L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020230j · Cited by 106
Becattini, B., Culmsee, C., Leone, M., Zhai, D., Zhang, X., Crowell, K. J., Rega, M. F., Landshamer, S., Reed, J. C., Plesnila, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603460103 · Cited by 94
Lesuisse, D., Lange, G., Deprez, P., Bénard, D., Schoot, B. M., Delettre, G., Marquette, J.-P., Broto, P., Jean‐Baptiste, V., Bichet, P., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010927p · Cited by 90
Discovery of novel inhibitors of Bcl-xL using multiple high-throughput screening platforms
Qian, J., Voorbach, M. J., Huth, J. R., Coen, M. L., Zhang, H., Ng, S., Comess, K. M., Petros, A. M., Rosenberg, S. H., Warrior, U., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.12.034 · Cited by 77
Jacoby, E., Schuffenhauer, A., Popov, M., Azzaoui, K., Havill, B., Schopfer, U., Engeloch, C., Staněk, J., Acklin, P., Rigollier, P., et al. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053828376 · Cited by 76
Warner, S. L., Bashyam, S., Vankayalapati, H., Bearss, D. J., Han, H., Hoff, D. D. V., & Hurley, L. H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0524 · Cited by 69
Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments
Hajduk, P. J., Gomtsyan, A. R., DiDomenico, S., Cowart, M., Bayburt, E. K., Solomon, L. R., Severin, J. M., Smith, R. A., Walter, K. A., Holzman, T. F., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000373a · Cited by 64
Self-citationIntegration of NMR and High-Throughput Screening
Hajduk, P. J., & Burns, D. J. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329996 · Cited by 63
Self-citationLange, G., Lesuisse, D., Deprez, P., Schoot, B. M., Loenze, P., Bénard, D., Marquette, J.-P., Broto, P., Sarubbi, E., & Mandine, E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020970s · Cited by 56
Hardy, L. W., & Peet, N. P. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02969-6 · Cited by 46
Site-directed structure generation by fragment-joining
Böhm, H. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174465 · Cited by 28
Structural analysis of caspase-1 inhibitors derived from Tethering
O'Brien, T., Fahr, B. J., Sopko, M. M., Lam, J. W., Waal, N. D., Raimundo, B. C., Purkey, H. E., Pham, P., & Romanowski, M. J. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105010109 · Cited by 26
Genomics: success or failure to deliver drug targets?
Betz, U. A. K., Farquhar, R., & Ziegelbauer, K. B. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.05.001 · Cited by 24
Cited by
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
Discovery of microbial natural products by activation of silent biosynthetic gene clusters
Rutledge, P. J., & Challis, G. L. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3496 · Cited by 986
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Metadata
- Authors
- Hajduk, P. J., & Greer, J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-02-09
- Volume
- 6
- Issue
- 3
- Pages
- 211-219
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2046258407
- Cited by
- 1,064
- References
- 62
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.